The Quality Improvement Plan describes the approach taken across the NATCAN cancer audits to develop improvement goals and performance indicators, ensuring these are measurable, actionable and improvable.
The NNHLA Quality Improvement goals, developed following a thorough scoping exercise in 2023 and in consultation with stakeholders in the Clinical Reference Group (CRG) are as follows:
- Improving timely diagnosis and treatment
- Treatment appropriate to the subtype of NHL
- Improving safety and reducing toxicity of NHL therapy
- Improving overall survival
- Reducing variation in NHL management among NHS providers.
The NNHLA has identified eleven performance indicators, which are mapped to these five quality improvement goals and clinical guidelines. It sets out improvement methods, improvement activities and approaches to evaluation of the Quality Improvement Plan.